Profile | GDS4284 / 210994_x_at |
Title | Chronic lymphocytic leukemia response to antisense Bcl-2 inhibitor SPC2996: peripheral blood |
Organism | Homo sapiens |
Sample | Title | Value | Rank |
---|---|---|---|
GSM687644 | Patient 401 control | 719.401 | 69 |
GSM687648 | Patient 402 control | 323.178 | 57 |
GSM687653 | Patient 403 control | 552.568 | 66 |
GSM687658 | Patient 404 control | 103.376 | 35 |
GSM687663 | Patient 411 control | 304.159 | 55 |
GSM687668 | Patient 422 control | 666.198 | 68 |
GSM687673 | Patient 424 control | 290.431 | 54 |
GSM687678 | Patient 425 control | 318.877 | 55 |
GSM687683 | Patient 427 control | 376.111 | 58 |
GSM687688 | Patient 428 control | 214.721 | 50 |
GSM687695 | Patient 441 control | 95.1206 | 25 |
GSM687699 | Patient 443 control | 162.585 | 40 |
GSM687704 | Patient 444 control | 333.226 | 57 |
GSM687707 | Patient 448 control | 676.409 | 68 |
GSM687712 | Patient 449 control | 466.079 | 62 |
GSM687719 | Patient 450 control | 256.622 | 50 |
GSM687724 | Patient 451 control | 743.839 | 70 |
GSM687728 | Patient 452 control | 721.33 | 70 |
GSM687646 | Patient 401 treated 24h | 717.628 | 68 |
GSM687649 | Patient 402 treated 24h | 578.249 | 66 |
GSM687665 | Patient 411 treated 24h | 334.7 | 56 |
GSM687651 | Patient 402 treated 4 weeks | 279.804 | 53 |
GSM687667 | Patient 411 treated 4 weeks | 635.898 | 67 |
GSM687670 | Patient 422 treated 24h | 672.794 | 67 |
GSM687671 | Patient 422 treated 4 weeks | 630.337 | 67 |
GSM687654 | Patient 403 treated 24h | 410.924 | 61 |
GSM687675 | Patient 424 treated 24h | 487.712 | 62 |
GSM687685 | Patient 427 treated 24h | 304.504 | 55 |
GSM687656 | Patient 403 treated 4 weeks | 496.062 | 64 |
GSM687677 | Patient 424 treated 4 weeks | 134.152 | 41 |
GSM687687 | Patient 427 treated 4 weeks | 731.362 | 69 |
GSM687692 | Patient 428 treated 4h | 179.59 | 46 |
GSM687716 | Patient 449 treated 4h | 475.184 | 63 |
GSM687722 | Patient 450 treated 4h | 55.6363 | 22 |
GSM687680 | Patient 425 treated 24h | 179.054 | 46 |
GSM687690 | Patient 428 treated 24h | 320.557 | 58 |
GSM687700 | Patient 443 treated 24h | 201.898 | 41 |
GSM687705 | Patient 444 treated 24h | 32.1482 | 18 |
GSM687714 | Patient 449 treated 24h | 415.118 | 61 |
GSM687721 | Patient 450 treated 24h | 278.186 | 51 |
GSM687682 | Patient 425 treated 4 weeks | 198.515 | 49 |
GSM687694 | Patient 428 treated 4 weeks | 185.969 | 49 |
GSM687702 | Patient 443 treated 4 weeks | 71.0433 | 27 |
GSM687718 | Patient 449 treated 4 weeks | 198.463 | 48 |
GSM687723 | Patient 450 treated 4 weeks | 272.747 | 53 |
GSM687661 | Patient 404 treated 4h | 106.055 | 34 |
GSM687710 | Patient 448 treated 4h | 667.853 | 69 |
GSM687726 | Patient 451 treated 4h | 1095.09 | 75 |
GSM687730 | Patient 452 treated 4h | 121.513 | 25 |
GSM687660 | Patient 404 treated 24h | 20.7572 | 7 |
GSM687697 | Patient 441 treated 24h | 370.518 | 56 |
GSM687709 | Patient 448 treated 24h | 606.845 | 67 |
GSM687725 | Patient 451 treated 24h | 608.109 | 66 |
GSM687729 | Patient 452 treated 24h | 98.0513 | 27 |
GSM687727 | Patient 451 treated 4 weeks | 793.635 | 70 |
GSM687731 | Patient 452 treated 4 weeks | 583.698 | 65 |